AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Duloxetine Hydrochloride Equivalent To Duloxetine

12 registrations across 1 African market— 8 active

Markets with Duloxetine Hydrochloride Equivalent To Duloxetine

Recent registrations

Brand / ProductMarketHolderStatusExpires
CYMBALTA 60🇿🇦South AfricaEli Lilly (S.A.) (Pty) LtdsuspendedApr 2025
CYMBALTA 30🇿🇦South AfricaEli Lilly (S.A.) (Pty) LtdsuspendedApr 2025
DULOXETINE DR 30 TEVA🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedDec 2022
DULOXETINE DR 60 TEVA🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedDec 2022
YELATE 30🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
SAVALRED 30🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
CYmgEN 60🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
YELATE 60🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
DULOXETINE MR 30 UNICORN🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJan 1900
DULOXETINE MR 60 UNICORN🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJan 1900
CYmgEN 30🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
SAVALRED 60🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900

Duloxetine Hydrochloride Equivalent To Duloxetine in Africa — Regulatory Overview

Duloxetine Hydrochloride Equivalent To Duloxetine is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 8 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.